Mentor Capital Stock Price, News & Analysis

Mentor Capital (OTCQB: MNTR) reported a strong 28% annualized sales growth, reaching $7,705,715 for the year ending December 31, 2022. The company's gross profit also increased by 18.95% to $2,226,322. Despite this growth, Mentor incurred a net loss of $471,386, translating to 2.1 cents per share. The share price closed the year at $0.05, with a market cap of $1,147,068. The firm has 22,941,357 common shares outstanding and plans to repurchase 255,252 shares. Mentor aims to expand in Texas, particularly in the energy sector.

Mentor Capital, Inc. (OTCQB: MNTR) reported annualized sales of $7,034,692 and a net profit of 0.9 cents per share for the six months ending June 30, 2022. This marks a 38.0% increase in revenue compared to the same period last year. The company achieved gross profits of $1,283,852, up 57.5% year-over-year. The share price stands at $0.04, with a market cap of $917,654. Notably, the Series Q convertible preferred stock now values at $19,219.11 per share.

Mentor Capital, Inc. (OTCQB: MNTR) reported quarterly revenues of $1,848,898 for the quarter ending March 31, 2022, marking a 40% increase year-over-year. Gross profit also rose by 60%, reaching $699,883. Despite these gains, the company reported a net loss of (0.4 cents) per share. Mentor's annualized sales per share at $0.32 significantly exceed the current share price of $0.05. The firm has invested $396,666 in legal funding related to a lawsuit against Aurora Cannabis.

Mentor Capital, Inc. (OTCQB: MNTR) announced a 25% revenue increase in 2021, reaching $6,010,438, compared to $4,825,956 in 2020. Gross profit rose to $1,871,653, although the company reported a net loss of $272,848. The divestment of cannabis assets resulted in an 11.6% increased valuation of preferred shares to $18,082. Cash reserves at year-end were $453,939, with a book value decline to $2,078,677. The company plans further share repurchases in 2022.

Mentor Capital (MNTR) reported a significant revenue increase of 21.2% in Q3 2021, achieving $1.49 million in quarterly revenues. The gross profit also improved by 30%, totaling $488,584. The trailing twelve-month revenue reached $5.47 million, marking a 15.2% year-over-year growth. The company’s market capitalization stands at $2.02 million.

Mentor's growth was largely driven by its subsidiary, Waste Consolidators, Inc., which reported $4.8 million in revenue for 2020. Additionally, the company successfully forgave a $77,121 Paycheck Protection Program loan.

Mentor Capital (OTCQB: MNTR) reported an 18.4% revenue increase and a 2.8% gross profit rise for Q2 2021 compared to Q2 2020. Trailing twelve-month revenues grew 15% to $5.21 million. However, the company incurred a net loss of $216,620 or 0.9 cents per share this quarter, worse than last year's loss of $184,185. Revenue growth is largely attributed to its subsidiary, Waste Consolidators, which reported a revenue increase from $4.2 million in 2019 to $4.8 million in 2020. Mentor's market capitalization stands at $2.46 million, with shares closing at 10.8 cents on August 13, 2021.

Mentor Capital (OTCQB: MNTR) reported a 15% revenue increase in Q1 2021, totaling $1.32 million, compared to Q1 2020. Trailing twelve-month revenues rose 14% to $5 million, with a net loss of $146,923. The net loss per share improved to (0.6 cents) from (1.1 cents) year-over-year. The company attributed growth to expansion into Texas, reduced COVID-19 impacts, and exploration in the crypto sector. As of March 31, 2021, Mentor had 22.85 million shares outstanding and a market cap of $3.77 million, up from $1.85 million at the 2020 year-end closing price.

Mentor Capital, Inc. (OTCQB: MNTR) has announced participation in the Coinbase IPO, reallocating funds from its Covid-19 initiatives and public vaccine companies. CEO Chet Billingsley highlighted the IPO's significance for Bitcoin and crypto's acceptance in finance. The company aims to assist private crypto startups in accessing public markets, potentially reducing volatility. With only 32 out of 40,000 public companies holding crypto assets, Mentor intends to contribute to this growing number.

Mentor Capital (OTCQB: MNTR) has introduced a complimentary metal lapel pin for shareholders, symbolizing vaccination against COVID-19 with Pfizer, Moderna, or AstraZeneca vaccines. The pin, stating “Covid-19 Antibodies,” aims to foster confidence in public spaces as areas move towards maskless environments. Shareholders can request the pin by mailing a self-addressed stamped envelope to the company. Furthermore, this initiative supports a non-profit, Antibody Badge, promoting vaccine awareness. The offer is available while supplies last.